Prime Therapeutics lands No. 3 spot on Minneapolis/St. Paul Business Journal’s 2020 Top 100 Private Companies List

For a third consecutive year, The Minneapolis/St. Paul Business Journal placed Prime at No. 3 on its 2020 Top 100 Private Companies List. Once again, Prime shares the top three with Cargill and CHS.

The annual list ranks companies by revenue. To qualify for the ranking, a company must have headquarters in Minnesota, be a for-profit operation and not issue stock to the public.

The full Top 100 Private Companies List is available now online and will publish in the Minneapolis/St. Paul Business Journal’s annual Book of Lists later this year.

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization serving health plans, employers and government programs. Prime is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Magellan Rx Management, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information visit www.primetherapeutics.com and www.magellanrx.com, or follow us on Twitter at @Prime_PBM and @Magellan_Rx.

Prime Therapeutics lands No. 3 spot on Minneapolis/St. Paul Business Journal’s 2020 Top 100 Private Companies List

About Prime Therapeutics

Related news

Prime Together Foundation supports Casa Esperanza, New Mexico’s House of Hope

Prime’s SIU team tracking the rise of drug-related schemes on social media

The Healthcare Businesswomen’s Association Rochester chapter honors Dr. Marci Chodroff with Everest Award for exemplary volunteer service